Results 221 to 230 of about 76,053 (241)

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Annals of Oncology, 2009
M Lichinitser
exaly  

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorin

Annals of Oncology, 2002
C Twelves, E Bajetta, R Bugat
exaly  

Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group

Annals of Oncology, 2017
A J van de Wouw, M Los, Erik van Werkhoven   +2 more
exaly  

The role of pharmacogenetics in capecitabine efficacy and toxicity

Cancer Treatment Reviews, 2016
Henk-Jan Guchelaar, E Boven
exaly  

Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer

Annals of Oncology, 2003
M Zeuli, T Gamucci, Virginia Ferraresi   +2 more
exaly  

Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane

Annals of Oncology, 2018
Miguel Martin, Mario Campone, Igor Bondarenko   +2 more
exaly  

Capecitabine

Reactions Weekly, 2009
openaire   +1 more source

A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer

Annals of Oncology, 2005
D W Rea, J W R Nortier, W W ten Bokkel Huinink   +2 more
exaly  

Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma

Annals of Oncology, 2009
S A Im, T Y Kim, Y J Bang
exaly  

Capecitabine in early breast cancer: A meta-analysis of randomised controlled trials

European Journal of Cancer, 2017
Josee-Lyne Ethier, Eitan Amir, David W Cescon   +2 more
exaly